Wednesday, December 30, 2020

Glenmark Pharma gets USFDA nod for erectile dysfunction treatment drug

Glenmark Pharma gets USFDA nod for erectile dysfunction treatment drug Glenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Tadalafil tablets USP in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3hzEsrl

No comments:

Post a Comment

India a key beneficiary of global portfolio diversification: Jonathan Schiessl

Global equities are performing well despite concerns about tariffs and geopolitical issues. Investors are seemingly ignoring negative news, ...